US20040199004A1 - Novel mesogens - Google Patents

Novel mesogens Download PDF

Info

Publication number
US20040199004A1
US20040199004A1 US10/811,090 US81109004A US2004199004A1 US 20040199004 A1 US20040199004 A1 US 20040199004A1 US 81109004 A US81109004 A US 81109004A US 2004199004 A1 US2004199004 A1 US 2004199004A1
Authority
US
United States
Prior art keywords
groups
group
mesogens
polymerizable
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/811,090
Inventor
Stephen Wellinghoff
Douglas Hanson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southwest Research Institute SwRI
Original Assignee
Southwest Research Institute SwRI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/056,121 external-priority patent/US7238831B2/en
Application filed by Southwest Research Institute SwRI filed Critical Southwest Research Institute SwRI
Priority to US10/811,090 priority Critical patent/US20040199004A1/en
Assigned to SOUTHWEST RESEARCH INSTITUTE reassignment SOUTHWEST RESEARCH INSTITUTE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HANSON, DOUGLAS P., WELLINGHOFF, STEPHEN T.
Publication of US20040199004A1 publication Critical patent/US20040199004A1/en
Assigned to NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT reassignment NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS). Assignors: SOUTHWEST RESEARCH INSTITUTE
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/20Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers
    • C09K19/2007Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers the chain containing -COO- or -OCO- groups
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0448Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Mesogens having the following general formula:
Figure US20040199004A1-20041007-C00001
wherein
X and Y independently are selected from the group consisting of amino groups, polymerizable groups, and groups having the following general structure:
Figure US20040199004A1-20041007-C00002
 wherein Z is selected from the group consisting of terminal functionalities and polymerizable groups; provided that when X is a polymerizable group, Y is an amino group;
R2 is a bulky organic group having a bulk greater than R1 and R3 whereby, when both X and Y are polymerizable groups, said bulk is adapted to provide sufficient steric hindrance to achieve a nematic state at room temperature while suppressing crystallinity at room temperature, thereby providing effective rheology and workability at room temperature; and
R1 and R3 are selected from groups less bulky than R2 adapted to maintain said nematic state.

Description

    PRIORITY DATA
  • The present application is a continuation-in-part of application Ser. No. 10/056,121 filed Jan. 23, 2002, pending, incorporated herein by reference, which claims the benefit of the following provisional applications, all filed Jan.23, 2001: Ser. No. 60/263,387; Ser. No. 60/263,392; Ser. No. 60/263,388.[0001]
  • GOVERNMENT RIGHTS CLAUSE
  • [0002] The U.S. government has certain rights in this invention pursuant to grant number NIDCR 1 P01 DE11688.
  • FIELD OF THE APPLICATION
  • The invention relates to novel mesogens. [0003]
  • BACKGROUND
  • Photocurable resins which are transparent or translucent, radioopaque, have good workability, and have good mechanical strength and stability are useful in medical, dental, adhesive, and stereolithographic applications. [0004]
  • Low polymerization shrinkage is an important property for such resins. In dental applications, the phrase “zero polymerization shrinkage” typically means that the stresses accumulated during curing do not debond the dentin-restorative interface or fracture the tooth or restorative, which can result in marginal leakage and microbial attack of the tooth. Low polymerization shrinkage also is important to achieve accurate reproduction of photolithographic imprints and in producing optical elements. [0005]
  • Another advantageous property for such resins is maintenance of a liquid crystalline state during processing. For comfort in dental applications, the resin should be curable at “room temperature,” defined herein as typical ambient temperatures up to body temperature. Preferred curing temperatures are from about 20° C. to about 37° C. Mesogens which have been found to polymerize in a relatively stable manner at such temperatures are bis 1,4[4′-(6′-methacryloxyhexyloxy) benzoyloxy] t-butylphenylene mesogens and their structural derivatives. These mesogens have the following general structure: [0006]
    Figure US20040199004A1-20041007-C00003
  • Known synthetic methods for producing these mesogens are costly and have relatively low yields. New synthetic methods and new methods and compositions for controlling rheology of these photocurable resins are needed. [0007]
  • SUMMARY
  • Mesogens are provided having the following general formula: [0008]
    Figure US20040199004A1-20041007-C00004
  • wherein [0009]
  • X and Y independently are selected from the group consisting of amino groups, polymerizable groups, and groups having the following general structure: [0010]
    Figure US20040199004A1-20041007-C00005
  • wherein Z is selected from the group consisting of a terminal functionality and a polymerizable group; provided that when X is a polymerizable group, Y is an amino group; [0011]  
  • R[0012] 2 is a bulky organic group having a bulk greater than R1 and R3 whereby, when both X and Y are polymerizable groups, said bulk is adapted to provide sufficient steric hindrance to achieve a nematic state at room temperature while suppressing crystallinity at room temperature, thereby providing effective rheology and workability at room temperature; and
  • R[0013] 1 and R3 are selected from groups less bulky than R2 adapted to maintain said nematic state.
  • DETAILED DESCRIPTION
  • The application provides novel having the following general formula: [0014]
    Figure US20040199004A1-20041007-C00006
  • wherein [0015]
  • X and Y independently are selected from the group consisting of amino groups, polymerizable groups, and groups having the following general structure: [0016]
    Figure US20040199004A1-20041007-C00007
  • wherein Z is selected from the group consisting of a terminal functionality and a polymerizable group; provided that when X is a polymerizable group, Y is an amino group; [0017]  
  • R[0018] 2 is a bulky organic group having a bulk greater than R1 and R3 whereby, when both X and Y are polymerizable groups, said bulk is adapted to provide sufficient steric hindrance to achieve a nematic state at room temperature while suppressing crystallinity at room temperature, thereby providing effective rheology and workability at room temperature; and
  • R[0019] 1 and R3 are selected from groups less bulky than R2 adapted to maintain said nematic state.
  • Suitable R[0020] 2 groups generate asymmetry in the packing of the molecules, and include, but are not necessarily limited to alkyl groups having from about 1 to 6 carbon atoms and aryl groups. Preferred R2 groups include, but are not necessarily limited to alkyl groups having from about 1 to about 4 carbon atoms and phenyl groups. More preferred R2 groups are methyl groups, t-butyl groups, isopropyl groups, secondary butyl groups, and phenyl groups. Most preferred R2 groups are methyl groups and t-butyl groups. Preferred R1 and R3 groups are selected from the group consisting of hydrogen atoms and methyl groups, depending upon the relative bulk of R1, R3, and R2.
  • “Terminal functionalities” are defined as protective groups and precursors to polymerizable groups, which generally comprise functionalities that readily react with “polymerizable groups” to form reactive ends. Suitable terminal functionalities independently are selected from the group consisting of hydroxyl groups, amino groups, sulfhydryl groups, halogen atoms, “spacer groups”, and groups comprising “spacer groups,” particularly spacer groups comprising a terminal functionalities selected from the group consisting of hydroxyl groups, amino groups, sulfhydryl groups, and halogen atoms. “Spacer groups” are defined herein as selected from the group consisting of H—(CH[0021] 2)n—O— groups, Cl(CH2)n—O— groups, Br(CH2)n—O— groups, I(CH2)n—O—, wherein n is from about 2 to about 12, preferably from about 2 to about 9, more preferably from about 2 to about 6, and most preferably 6, and the CH2 groups independently can be substituted by oxygen, sulfur, or an ester group; provided that at least 2 carbon atoms separate said oxygen or said ester group.
  • Where the mesogen is a polymerizable mesogen, X and/or Y are “polymerizable groups,” defined as groups that may be polymerized by nucleophilic addition, free radical polymerization, or a combination thereof. Preferred polymerizable groups are polymerizable by Michael addition. Michael addition requires the addition of a nucleophile and an electron deficient alkene. Groups suitable for polymerization by Michael addition include but are not necessarily limited to the examples found in A. Michael, [0022] J. Prakt. Chem. [2] 35, 349 (1887); R. Connor and W. R. McClelland, J. Org. Chem., 3, 570 (1938); and C. R. Hauser, M. T. Tetenbaum, J. Org. Chem., 23, 1146 (1959), all of which are incorporated by reference herein.
  • Examples of suitable polymerizable groups include, but are not necessarily limited to substituted and unsubstituted alkenyl ester groups comprising a polymerizable unsaturated carbon-carbon bond, wherein said alkenyl group has from about 2 to about 12 carbon atoms, preferably from about 2 to about 9 carbon atoms, more preferably from about 2 to about 6 carbon atoms. In one embodiment, said substituted alkenyl ester groups comprise at least one halogen atom selected from the group consisting of chorine atoms, bromine atoms, and iodine atoms. Preferred alkenyl esters are acryloyloxy alkoxy groups and methacryloyloxy alkoxy groups. More preferred polymerizable groups include, but are not necessarily limited to cinnamoyloxy groups, acryloyloxy groups, methacryloxy groups, as well as thioalkyloxy groups, acryloyloxy alkoxy groups, and methacryloyloxy alkoxy groups comprising an alkyl moiety having from about 2 to about 12 carbon atoms, preferably about 6 carbon atoms, said alkyl moieties comprising CH[0023] 2 groups which independently can be substituted by oxygen, sulfur, or an ester group; provided that at least 2 carbon atoms separate said oxygen or said ester group. Because asymmetry suppresses crystallinity while maintaining a nematic state, it is preferred for X and Y to be different groups.
  • Mesomers of higher temperature nematic stability are “mesogenic dimers,” formed by reacting X or Y on separate mesogen molecules with opposite ends of a bridging agent. Examples of suitable bridging agents include, but are not necessarily limited to dicarboxylic acids (preferably α,ω-carboxylic acids) having from about 4 to about 12 carbon atoms, preferably from about 6 to about 10 carbon atoms, and oligodialkylsiloxanes preferably comprising alkyl groups having from about 1 to about 3 carbon atoms, most preferably methyl groups. When the mesomer is a dimer or another structure comprising components that inherently interfere with crystallization at room temperature, R[0024] 2 need not have a bulk greater than R1 and R3. Hence, R2 may be hydrogen, a halogen atom, or another substituent having lesser bulk than a methylene group.
  • Depending on the sample preparation, the volumetric photopolymerization shrinkage of these materials at room temperature varies from about 0.9 to about 1.7%, which is a factor of 6-4X improvement over commercially available blends containing 2,2-bis[p-(2′-hydroxy-3′-methacryloxypropoxy)phenylene] propane (“bis-GMA”). Preferably, the polymerizable mesogens exhibit “low polymerization shrinkage,” defined herein as about 3 vol. % change or less, preferably about 2 vol. % change or less. [0025]
  • Dimers [0026]
  • The following is a ChemSketch 4 rendition of the minimum energy conformation of {C0[H,TB,H] (MeAcry)(O)}[0027] 2(seb). As expected the most stable conformation is an extended form with a very high molecular length to width ratio which is likely to form high Tn->I liquid crystal monomers.
    Figure US20040199004A1-20041007-P00001
  • A minimum energy conformation of a preferred mesogenic dimer is decanedioic acid bis-(4-{2-tert-butyl-4-[4-(2-methyl-acryloyloxy)-benzoyloxy]-phenoxycarbonyl}-phenyl) ester {C0[H,TB,H] (MeAcry)(O)}[0028] 2(seb):
    Figure US20040199004A1-20041007-C00008
  • An exemplary novel mesogen is alkylenedioic bis-(4-{2-alkyl-4-[4-(hydroxy)-benzoyloxy]-phenoxycarbonyl}-phenyl) ester having the following general structure: [0029]
    Figure US20040199004A1-20041007-C00009
  • wherein [0030]
  • R[0031] 4 has from about 2 to about 20 carbon atoms, preferably from about 2 to about 12 carbon atoms, and most preferably from about 6 to about 12 carbon atoms.
  • the alkyl substituent on the central aromatic group of the aromatic ends includes, but is not necessarily limited to t-butyl groups, isopropyl groups, and secondary butyl groups. Most preferred are t-butyl groups; and, [0032]
  • V and W are selected from the group consisting of terminal functionalities and polymerizable groups. In platform molecules, V and W are terminal functionalities. In polymerizable mesogens, V and/or W are polymerizable groups. [0033]
  • Additional exemplary mesogens have the following general structure: [0034]
    Figure US20040199004A1-20041007-C00010
  • wherein [0035]
  • R[0036] 5 and R6 are selected from the group consisting of hydrogen, halogen, n-alkyl groups having from about 1 to 6 carbon atoms, aryl groups, and bulky organic groups; and,
  • V and W independently are selected from the groups comprising polymerizable groups and terminal functionalities. [0037]
  • Suitable terminal functionalities independently are selected from the group consisting of hydroxyl groups, amino groups, and sulfhydryl groups. Most preferred terminal functionalities are hydroxyl groups. [0038]
  • Suitable polymerizable groups may be polymerized by nucleophilic addition, free radical polymerization, or a combination thereof. Preferred polymerizable groups are polymerizable by Michael addition. Michael addition requires the addition of a nucleophile and an electron deficient alkene. Groups suitable for polymerization by Michael addition include but are not necessarily limited to the examples found in A. Michael, [0039] J. Prakt. Chem. [2] 35, 349 (1887); R. Connor and W. R. McClelland, J. Org Chem., 3, 570 (1938); and C. R. Hauser, M. T. Tetenbaum, J. Org Chem., 23, 1146 (1959), all of which are incorporated by reference herein.
  • Examples of suitable polymerizable groups include, but are not necessarily limited to substituted and unsubstituted alkenyl ester groups comprising a polymerizable unsaturated carbon-carbon bond, wherein said alkenyl group has from about 2 to about 12 carbon atoms, preferably from about 2 to about 9 carbon atoms, more preferably from about 2 to about 6 carbon atoms. Preferred alkenyl esters are acryloyl alkoxy groups, methacryloyloxy alkoxy groups, acryloyloxy groups, and methacryloyloxy groups. V and W may be the same or different, depending upon the application. In a preferred application—a dental application—V and W comprise terminal alkenyl groups. [0040]
  • These alkylenedioic bis-(4-{2-alkyl-4-[4-(hydroxy)-benzoyloxy]-phenoxycarbonyl}-phenyl) esters are novel compounds, and may be used as “platform molecules,” or polymerizable mesogens. A most preferred alkylenedioic bis-(4-{2-alkyl-4-[4-(hydroxy)-benzoyloxy]-phenoxycarbonyl}-phenyl) ester is decanedioic acid bis-(4-{2-tert-butyl-4-[4-(hydroxy)-benzoyloxy] -phenoxycarbonyl}-phenyl) ester. [0041]
  • Low Polymerization Shrinkage [0042]
  • The mesogens exhibit “low polymerization shrinkage” preferably no more than 3 vol. % change, more preferably no more than about 2 volume percent change. Polymerization shrinkage is measured by codissolving the monomers in dichloromethane with 0.3 wt. % camphorquinone photoinitiator, 100 ppm benzoquinone and 1 wt. % N,N′ dimethylaminoethyl methacrylate activator and subsequently pumping off the solvent, all under yellow light. The monomers are then polymerized in film or droplet form in less than 1 minute by exposure to a dental curing light (Dentsply Spectrum Curing Lamp) with a significant output at 420 nm. [0043]
  • FTIR spectroscopy (Nicolet Magna-IR 560) is used to measure the degree of cure by observing the decrease in the 1637 cm[0044] −1 alkene band vs. the aromatic internal thickness band at 1603 cm−1. Thin film measurements that avoid oxygen inhibition are performed by sandwiching the monomer between polyvinylidene chloride films, which have an optical window in the wavelength region of interest. The IR spectrum of solid droplets is evaluated using a single bounce reflectance measurement. The flat bottom surface of the droplet is pressed against the germanium lens of a Spectra Tech Thunderdome attachment.
  • Polymerization of the monomers can be observed between transparent polyvinylidene chloride films under cross-polarized optical microscopy in the heated stage of a Nikon Optimat microscope. Little change in the local birefringence and thus local orientation is noted upon polymerization at room temperature or upon heating to 180° C. [0045]
  • Fracture Toughness [0046]
  • Compact tension samples (ASTM E399) with known edge crack length are fabricated by photocuring the monomer with initiator and activator in silicone molds. After polishing the surface with 600 grit polishing agent and soaking in physiologic saline at 37° C. for 24 hours the samples were tested at room temperature under displacement control at 1 mm/min until failure. [0047]
  • The fracture toughness of the crosslinked, amorphous glass suitable is about 0.4 MPa-m[0048] 1/2, preferably about 0.5 MPa-m1/3, which is identical to that found for photocured, isotropic dimethacrylate based resins such as GTE resin.
  • Fillers [0049]
  • Considerable amounts of soluble impurity can be added to the polymerizable mesogens, or a mixture comprising the polymerizable mesogens, without changing the T[0050] nematic->isotropic transition temperature of the polymerizable mesogens. Thus, a high volume fraction of filler can be added to the polymerizable mesogens and still form a composite that maintains desirable, low viscosity flow and low polymerization shrinkage characteristics at temperatures of curing. Commercial products add up to about 70-80 wt % filler. A preferred embodiment uses about 30 wt. % filler.
  • A variety of fillers may be used, including but not necessarily limited to silica fillers, glass fillers, and amphoteric nano-sized metal oxide particles. Preferred fillers are amphoteric nano-sized metal oxide particles having a diameter in nanometers which is sufficiently small to provide transparency effective for photopolymerization but sufficiently large to provide effective fracture toughness after photopolymerization. Substantially any “metal” capable of forming an amphoteric metal oxide may be used to form the metal oxide particles. Suitable metallic elements include, but are not necessarily limited to niobium, indium, titanium, zinc, zirconium, tin, cerium, hafnium, tantalum, tungsten, and bismuth. Also suitable in place of the metal in the oxide is the semi-metallic compound, silicon. As used herein, unless otherwise indicated, the term “metal oxide” is defined to include silicon, and the word “metal,” when used to refer to the metal oxide is intended to also refer to silicon. [0051]
  • The metal oxides may be made of a single metal, or may be a combination of metals, alone or combined with other impurities or “alloying” elements, including, but not necessarily limited to aluminum, phosphorus, gallium, germanium, barium, strontium, yttrium, antimony, and cesium. [0052]
  • A monomeric liquid crystal (LC) containing a high volume fraction of filler nanoparticles is a highly constrained system. As a result, at least for some monomeric species, both smectic and crystalline transitions should be suppressed. The consequent widening of the stability range of nematic mesophase should permit the composite to polymerize at much lower temperatures than in unfilled systems, resulting in lower polymerization shrinkage. [0053]
  • The metal oxide nanoparticles may be prepared using any known methods, such as “sol-gel” techniques, direct hydrolysis of metal alkoxides by water addition, forced hydrolysis of relatively low-cost metal salts, or non-hydrolytic reactions of metal alkoxides with metal halide salts. Examples of such procedures are shown in the following references, each of which is incorporated herein by reference: W. Stöber and A. Fink, J. of Colloid and Interface Science, v. 26, 62-69 (1968); M. Z.-C. Hu, M. T. Harris, and C. H. Byers, J. of Colloid and Interface Science, v. 198, 87-99 (1988); M. Ocaña and E. Matijević, J. of Materials Research, v. 5(5), 1083-1091 (1990); L. Lerot, F. LeGrand, P. de Bruycker, J. of Materials Science, v. 26, 2353-2358 (1991); H. Kumazawa, Y. Hori, and E. Sada, The Chemical Eng'g. Journal, v. 51, 129-133 (1993); S. K. Saha and P. Pramanik, J. of Non-Crystalline Solids, v. 159, 31-37 (1993); M. Andrianainarivelo, R. Corriu, D. Leclercq, P. H. Mutin, and A. Vioux, J. of Materials Chemistry, v. 6(10), 1665-1671 (1996); F. Garbassi, L. Balducci, R. Ungarelli, J. of Non-Crystalline Solids, v. 223, 190-199 (1998); J. Spatz, S. Mössmer, M. Mo[umlaut]ller, M. Kocher, D. Neher, and G. Wegner, Advanced Materials, v. 10(6), 473-475 (1998); R. F. de Farias, and C. Airoldi, J. of Colloid and Interface Science, v. 220, 255-259 (1999); T. J. Trentler, T. E. Denler, J. F. Bertone, A. Agrawal, and V. L. Colvin, J. of the Am. Chemical Soc., v. 121, 1613-1614 (1999); Z. Zhan and H. C. Zheng, J. of Non-Crystalline Solids, v. 243, 26-38 (1999); M. Lade, H. Mays, J. Schmidt, R. Willumeit, and R. Schomäcker, Colloids and Surfaces A: Physiochemical and Eng'g Aspects, v. 163, 3-15 (2000); and the procedure described in “Sol-gel processing with inorganic metal salt precursors,” authored by “Michael” Zhong Cheng Hu, licensable via Oak Ridge National Laboratory under ORNL control number ERID 0456. [0054]
  • Persons of ordinary skill in the art will recognize that many modifications may be made to the present invention without departing from the spirit and scope of the present invention. The embodiment described herein is meant to be illustrative only and should not be taken as limiting the invention, which is defined in the following claims. [0055]

Claims (62)

We claim:
1. Mesogens having the following general formula:
Figure US20040199004A1-20041007-C00011
wherein
X and Y independently are selected from the group consisting of amino groups, polymerizable groups, and groups having the following general structure:
Figure US20040199004A1-20041007-C00012
 wherein Z is selected from the group consisting of terminal functionalities and polymerizable groups; provided that when X is a polymerizable group, Y is an amino group;
R2 is a bulky organic group having a bulk greater than R1 and R3 whereby, when both X and Y are polymerizable groups, said bulk is adapted to provide sufficient steric hindrance to achieve a nematic state at room temperature while suppressing crystallinity at room temperature, thereby providing effective rheology and workability at room temperature; and
R1 and R3 are selected from groups less bulky than R2 adapted to maintain said nematic state.
2. The mesogens of claim 1 wherein said polymerizable groups are selected from the group comprising a polymerizable unsaturated carbon-carbon bond.
3. The mesogens of claim 1 wherein said polymerizable groups are selected from the group consisting of acryloyloxy alkoxy groups and methacryloyloxy alkoxy groups comprising an alkyl moiety having from 2 to 12 carbon atoms.
4. The mesogens of claim 3 wherein said alkyl moiety is selected from the group consisting of alkyl groups consisting of CH2 groups and alkyl groups wherein one or more of said CH2 groups comprises a substitute group selected from the group consisting of oxygen, sulfur, and an ester group; provided that at least 2 carbon atoms separate said oxygen from said ester group.
5. The mesogens of claim 3 wherein said alkyl moiety consists essentially of a total of from 2 to 9 groups selected from the group consisting of said CH2 groups and said substitute groups.
6. The mesogens of claim 3 wherein said alkyl moiety consists essentially of a total of from 2 to 6 groups selected from the group consisting of said CH2 groups and said substitute groups.
7. The mesogens of claim 1 wherein R2 is selected from the group consisting of alkyl groups having from about 1 to 6 carbon atoms and aryl groups.
8. The mesogens of claims 1 wherein R2 is selected from the group consisting of methyl groups, t-butyl groups, isopropyl groups, secondary butyl groups, and phenyl groups, preferably selected from the group consisting of a methyl group and a t-butyl group.
9. The mesogens of claims 3 wherein R2 is selected from the group consisting of methyl groups, t-butyl groups, isopropyl groups, secondary butyl groups, and phenyl groups, preferably selected from the group consisting of a methyl group and a t-butyl group.
10. The mesogens of claim 8 wherein R and R3 are selected from the group consisting of hydrogen and a methyl group.
11. The mesogens of any of claim 1 wherein said terminal functionalities comprise spacer groups.
12. The mesogens of claim 1 wherein said terminal functionalities independently are selected from the group consisting of hydroxyl groups, amino groups, sulfhydryl groups.
13. Mesogens having the following general formula:
Figure US20040199004A1-20041007-C00013
wherein
X and Y independently are selected from the group consisting of amino groups, polymerizable groups; provided that when X is a polymerizable group, Y is an amino group;
R2 is a bulky organic group having a bulk greater than R1 and R3 whereby, when both X and Y are polymerizable groups, said bulk is adapted to provide sufficient steric hindrance to achieve a nematic state at room temperature while suppressing crystallinity at room temperature, thereby providing effective rheology and workability at room temperature; and
R1 and R3 are selected from groups less bulky than R2 adapted to maintain said nematic state.
14. The mesogens of claim 13 wherein said polymerizable groups are selected from the group comprising a polymerizable unsaturated carbon-carbon bond.
15. The mesogens of claim 1 wherein said polymerizable groups are selected from the group consisting of acryloyloxy alkoxy groups and methacryloyloxy alkoxy groups comprising an alkyl moiety having from 2 to12 carbon atoms.
16. The mesogens of claim 15 wherein said alkyl moiety is selected from the group consisting of alkyl groups consisting of CH2 groups and alkyl groups wherein one or more of said CH2 groups comprises a substitute group selected from the group consisting of oxygen, sulfur, and an ester group; provided that at least 2 carbon atoms separate said oxygen from said ester group.
17. The mesogens of claim 16 wherein said alkyl moiety consists essentially of a total of from 2 to 9 groups selected from the group consisting of said CH2 groups and said substitute groups.
18. The mesogens of claim 16 wherein said alkyl moiety consists essentially of a total of from 2 to 6 groups selected from the group consisting of said CH2 groups and said substitute groups.
19. The mesogens of claim 13 wherein R2 is selected from the group consisting of alkyl groups having from about 1 to 6 carbon atoms and aryl groups.
20. The mesogens of claims 13 wherein R2 is selected from the group consisting of methyl groups, t-butyl groups, isopropyl groups, secondary butyl groups, and phenyl groups, preferably selected from the group consisting of a methyl group and a t-butyl group.
21. The mesogens of claims 15 wherein R2 is selected from the group consisting of methyl groups, t-butyl groups, isopropyl groups, secondary butyl groups, and phenyl groups, preferably selected from the group consisting of a methyl group and a t-butyl group.
22. The mesogens of claim 20 wherein R and R3 are selected from the group consisting of hydrogen and a methyl group.
23. The mesogens of claim 21 wherein R and R3 are selected from the group consisting of hydrogen and a methyl group.
24. The mesogens of any of claim 13 wherein at least one of X or Y comprises a spacer group.
25. The mesogens of any of claim 23 wherein at least one of X or Y comprises a spacer group.
26. The mesogens of claim 13 wherein at least one of X or Y is selected from the group consisting of cinnamoyloxy groups.
27. The mesogens of claim 23 wherein at least one of X or Y is selected from the group consisting of cinnamoyloxy groups.
28. Mesogens having the following general formula:
Figure US20040199004A1-20041007-C00014
wherein X and Y independently are selected from the group consisting of terminal functionalities and polymerizable groups, at least one of X and Y having the following general structure:
Figure US20040199004A1-20041007-C00015
 wherein Z is selected from the group consisting of terminal functionalities and polymerizable groups;
R2 is a bulky organic group having a bulk greater than R1 and R3 whereby, when both X and Y are polymerizable groups, said bulk is adapted to provide sufficient steric hindrance to achieve a nematic state at room temperature while suppressing crystallinity at room temperature, thereby providing effective rheology and workability at room temperature; and
R1 and R3 are selected from groups less bulky than R2 adapted to maintain said nematic state.
29. The mesogens of claim 28 wherein said terminal functionalities independently are selected from the group consisting of hydroxyl groups, amino groups, sulfhydryl groups, and spacer groups.
30. The mesogens of claim 28 wherein said terminal functionalities comprise spacer groups.
31. The mesogens of claim 29 wherein said terminal functionalities comprise spacer groups.
32. The mesogens of claim 28 wherein said polymerizable groups are selected from the group comprising a polymerizable unsaturated carbon-carbon bond.
33. The mesogens of claim 29 wherein said polymerizable groups are selected from the group comprising a polymerizable unsaturated carbon-carbon bond.
34. The mesogens of claim 30 wherein said polymerizable groups are selected from the group comprising a polymerizable unsaturated carbon-carbon bond.
35. The mesogens of claim 31 wherein said polymerizable groups are selected from the group comprising a polymerizable unsaturated carbon-carbon bond.
36. The mesogens of claim 28 wherein said polymerizable groups are selected from the group consisting of acryloyloxy alkoxy groups and methacryloyloxy alkoxy groups comprising an alkyl moiety having from 2 to12 carbon atoms.
37. The mesogens of claim 29 wherein said polymerizable groups are selected from the group consisting of acryloyloxy alkoxy groups and methacryloyloxy alkoxy groups comprising an alkyl moiety having from 2 to 12 carbon atoms.
38. The mesogens of claim 30 wherein said polymerizable groups are selected from the group consisting of acryloyloxy alkoxy groups and methacryloyloxy alkoxy groups comprising an alkyl moiety having from 2 to 12 carbon atoms.
39. The mesogens of claim 31 wherein said polymerizable groups are selected from the group consisting of acryloyloxy alkoxy groups and methacryloyloxy alkoxy groups comprising an alkyl moiety having from 2 to 12 carbon atoms.
40. The mesogens of claim 36 wherein said alkyl moiety is selected from the group consisting of alkyl groups consisting of CH2 groups and alkyl groups wherein one or more of said CH2 groups comprises a substitute group selected from the group consisting of oxygen, sulfur, and an ester group; provided that at least 2 carbon atoms separate said oxygen from said ester group.
41. The mesogens of claim 37 wherein said alkyl moiety is selected from the group consisting of alkyl groups consisting of CH2 groups and alkyl groups wherein one or more of said CH2 groups comprises a substitute group selected from the group consisting of oxygen, sulfur, and an ester group; provided that at least 2 carbon atoms separate said oxygen from said ester group.
42. The mesogens of claim 38 wherein said alkyl moiety is selected from the group consisting of alkyl groups consisting of CH2 groups and alkyl groups wherein one or more of said CH2 groups comprises a substitute group selected from the group consisting of oxygen, sulfur, and an ester group; provided that at least 2 carbon atoms separate said oxygen from said ester group.
43. The mesogens of claim 39 wherein said alkyl moiety is selected from the group consisting of alkyl groups consisting of CH2 groups and alkyl groups wherein one or more of said CH2 groups comprises a substitute group selected from the group consisting of oxygen, sulfur, and an ester group; provided that at least 2 carbon atoms separate said oxygen from said ester group.
44. The mesogens of claim 43 wherein said alkyl moiety consists essentially of a total of from 2 to 9 groups selected from the group consisting of said CH2 groups and said substitute groups.
45. The mesogens of claim 43 wherein said alkyl moiety consists essentially of a total of from 2 to 6 groups selected from the group consisting of said CH2 groups and said substitute groups.
46. The mesogens of claim 26 wherein R2 is selected from the group consisting of alkyl groups having from about 1 to 6 carbon atoms and aryl groups.
47. The mesogens of claim 35 wherein R2 is selected from the group consisting of alkyl groups having from about 1 to 6 carbon atoms and aryl groups.
48. The mesogens of claim 39 wherein R2 is selected from the group consisting of alkyl groups having from about 1 to 6 carbon atoms and aryl groups.
49. The mesogens of claim 43 wherein R2 is selected from the group consisting of alkyl groups having from about 1 to 6 carbon atoms and aryl groups.
50. The mesogens of claim 45 wherein R2 is selected from the group consisting of alkyl groups having from about 1 to 6 carbon atoms and aryl groups.
51. The mesogens of claims 26 wherein R2 is selected from the group consisting of methyl groups, t-butyl groups, isopropyl groups, secondary butyl groups, and phenyl groups, preferably selected from the group consisting of a methyl group and a t-butyl group.
52. The mesogens of claims 35 wherein R2 is selected from the group consisting of methyl groups, t-butyl groups, isopropyl groups, secondary butyl groups, and phenyl groups, preferably selected from the group consisting of a methyl group and a t-butyl group.
53. The mesogens of claims 39 wherein R2 is selected from the group consisting of methyl groups, t-butyl groups, isopropyl groups, secondary butyl groups, and phenyl groups, preferably selected from the group consisting of a methyl group and a t-butyl group.
54. The mesogens of claims 45 wherein R2 is selected from the group consisting of methyl groups, t-butyl groups, isopropyl groups, secondary butyl groups, and phenyl groups, preferably selected from the group consisting of a methyl group and a t-butyl group.
55. The mesogens of claims 43 wherein R2 is selected from the group consisting of methyl groups, t-butyl groups, isopropyl groups, secondary butyl groups, and phenyl groups, preferably selected from the group consisting of a methyl group and a t-butyl group.
56. The mesogens of claim 46 wherein R and R3 are selected from the group consisting of hydrogen and a methyl group.
57. The mesogens of claim 50 wherein R and R3 are selected from the group consisting of hydrogen and a methyl group.
58. The mesogens of claim 51 wherein R and R3 are selected from the group consisting of hydrogen and a methyl group.
59. The mesogens of claim 55 wherein R and R3 are selected from the group consisting of hydrogen and a methyl group.
60. The mesogens of claim 26 wherein at least one of X or Y is selected from the group consisting of cinnamoyloxy groups.
61. The mesogens of claim 55 wherein at least one of X or Y is selected from the group consisting of cinnamoyloxy groups.
62. The mesogens of claim 59 wherein at least one of X or Y is selected from the group consisting of cinnamoyloxy groups.
US10/811,090 2001-01-23 2004-03-26 Novel mesogens Abandoned US20040199004A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/811,090 US20040199004A1 (en) 2001-01-23 2004-03-26 Novel mesogens

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26339201P 2001-01-23 2001-01-23
US26338801P 2001-01-23 2001-01-23
US26338701P 2001-01-23 2001-01-23
US10/056,121 US7238831B2 (en) 2001-01-23 2002-01-23 Mesogens
US10/811,090 US20040199004A1 (en) 2001-01-23 2004-03-26 Novel mesogens

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/056,121 Continuation-In-Part US7238831B2 (en) 2001-01-23 2002-01-23 Mesogens

Publications (1)

Publication Number Publication Date
US20040199004A1 true US20040199004A1 (en) 2004-10-07

Family

ID=27489787

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/811,090 Abandoned US20040199004A1 (en) 2001-01-23 2004-03-26 Novel mesogens

Country Status (1)

Country Link
US (1) US20040199004A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020013382A1 (en) * 1999-05-19 2002-01-31 Furman Benjamin L. Methods of functionalizing and functionalized metal oxide particles and mechanically strong and transparent or translucent composites made using such particles
US20020177727A1 (en) * 2001-01-23 2002-11-28 Wellinghoff Stephen T. Novel mesogens
US20030125435A1 (en) * 2001-03-07 2003-07-03 Norling Barry K. Ultra-low shrinkage composite resins based on blended nematic liquid crystal monomers
US20030168633A1 (en) * 2001-07-09 2003-09-11 Wellinghoff Stephen T. Novel, mesogens and methods for their synthesis and use
US20040144954A1 (en) * 2001-01-23 2004-07-29 Southwest Research Institute Selective ether cleavage synthesis of liquid crystals

Citations (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201856A (en) * 1978-05-08 1980-05-06 Eastman Kodak Company Liquid crystal copolyesters containing terephthalic acid, 2,6-naphthalenedicarboxylic acid, hydroquinone and resorcinol
US4215033A (en) * 1978-09-08 1980-07-29 American Dental Association Health Foundation Composite dental material
US4539048A (en) * 1983-02-09 1985-09-03 Jos. Cavedon Company Inc. Aluminum zirconium metallo-organic complexes useful as coupling agents
USRE32073E (en) * 1980-09-08 1986-01-28 Minnesota Mining And Manufacturing Company Dental filling composition utilizing zinc-containing inorganic filler
US4588756A (en) * 1983-01-10 1986-05-13 American Dental Association Health Foundation Multi-step method for obtaining strong adhesive bonding of composites to dentin, enamel and other substrates
US4623738A (en) * 1985-04-22 1986-11-18 Kenrich Petrochemicals, Inc. Neoalkoxy organo-titanates and organo-zirconates useful as coupling and polymer processing agents
US4659751A (en) * 1983-01-10 1987-04-21 American Dental Association Health Foundation Simplified method for obtained strong adhesive bonding of composites to dentin, enamel and other substrates
US4663147A (en) * 1985-09-03 1987-05-05 International Minerals & Chemical Corp. Disc-like sustained release formulation
US4753652A (en) * 1984-05-04 1988-06-28 Children's Medical Center Corporation Biomaterial implants which resist calcification
US4914221A (en) * 1987-08-13 1990-04-03 Consortium Fur Elektrochemische Industrie Gmbh Dimethylsilyl-substituted benzoyl chlorides and a process for preparing the same
US4964911A (en) * 1987-10-13 1990-10-23 Den-Mat Corporation Adhesive bonding of acrylic resins, especially in dentistry
US4978640A (en) * 1988-02-24 1990-12-18 Massachusetts Institute Of Technology Dispersion strengthened composite
US5024850A (en) * 1989-05-10 1991-06-18 U.S. Philips Corporation Method of manufacturing a polarization filter and a polarization filter so obtained
US5030608A (en) * 1989-08-23 1991-07-09 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Process for the preparation of composite materials which contain small particles of metal or metal oxide in an oxide matrix and the composite materials prepared by the process
US5057018A (en) * 1986-05-13 1991-10-15 American Dental Association - Health Foundation Microcrystalline inserts for megafilled composite dental restorations
US5064877A (en) * 1988-07-18 1991-11-12 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Process for fixing inorganic species in an organic matrix
US5073294A (en) * 1990-03-07 1991-12-17 Hercules Incorporated Process of preparing compositions having multiple oriented mesogens
US5202053A (en) * 1991-02-22 1993-04-13 Hercules Incorporated Polymerizable nematic monomer compositions
US5276068A (en) * 1985-03-29 1994-01-04 Jeneric/Pentron, Inc. Dental resin materials
US5308886A (en) * 1990-04-20 1994-05-03 Japan Institute Of Advanced Dentistry Photosetting resin for making strong, tough resin articles
US5328947A (en) * 1991-12-27 1994-07-12 Denki Kagaku Kogyo Kabushiki Kaisha Two-part adhesive
US5334625A (en) * 1989-04-06 1994-08-02 Den-Mat Corporation Restorative dental adhesive composition
US5372796A (en) * 1993-04-13 1994-12-13 Southwest Research Institute Metal oxide-polymer composites
US5401528A (en) * 1991-03-19 1995-03-28 Thera Patent GmbH & Co. KG Geselleschaft fur industrielle Schutzrechte Use of compositions based on organically modified silicic acid polycondensates for coating teeth and dental prostheses
US5472797A (en) * 1992-07-07 1995-12-05 Hoya Corporation Optical elements having cured coating film
US5486548A (en) * 1993-07-21 1996-01-23 Bayer Aktiengesellschaft Acrylates and methacrylates based on cyclohexyldiphenols
US5502087A (en) * 1993-06-23 1996-03-26 Dentsply Research & Development Corp. Dental composition, prosthesis, and method for making dental prosthesis
US5556931A (en) * 1994-07-08 1996-09-17 Tokuyama Corporation Polymerizable composition and organic glass
US5563230A (en) * 1994-09-09 1996-10-08 National Science Council Chiral smectic liquid crystalline polymers
US5622648A (en) * 1993-10-15 1997-04-22 Merck Patent Gesellschaft Mit Beschrankter Haftung Reactive liquid crystal compounds
US5624976A (en) * 1994-03-25 1997-04-29 Dentsply Gmbh Dental filling composition and method
US5654471A (en) * 1994-12-01 1997-08-05 Consortium Fur Elektrochemische Industrie Gmbh Process for the preparation of 4-hydroxyphenyl benzoate derivatives
US5663214A (en) * 1995-04-17 1997-09-02 Gc Corporation Photocuring denture base lining material
US5695681A (en) * 1995-03-30 1997-12-09 Basf Aktiengesellschaft Liquid-crystalline allenes
US5720805A (en) * 1993-04-13 1998-02-24 Southwest Research Institute Titanium-tin-oxide nanoparticles, compositions utilizing the same, and the method of forming the same
US5730601A (en) * 1996-03-11 1998-03-24 The Regents Of The University Of Colorado Method and material for use with dental composites for improving conversion of monomers to polymers and reducing volume shrinkage
US5804097A (en) * 1993-09-25 1998-09-08 Basf Aktiengsellschaft Liquid-crystalline compounds
US5808108A (en) * 1997-01-15 1998-09-15 Chappelow; Cecil C. Polymeric compositions and composites prepared from spiroorthocarbonates and epoxy monomers
US5834532A (en) * 1993-08-02 1998-11-10 Sun Medical Co., Ltd. Primer composition and curable composition
US5833880A (en) * 1994-03-11 1998-11-10 Basf Aktiengesellschaft Polymerizable liquid-crystalline compounds
US5852248A (en) * 1998-05-21 1998-12-22 Den-Mat Corporation Method for accurate replication of shaped articles using sinterable powders
US5859089A (en) * 1997-07-01 1999-01-12 The Kerr Corporation Dental restorative compositions
US5865623A (en) * 1997-03-12 1999-02-02 Bisco, Inc. Flexible dental composite compositions and restorative methods using flexible dental compositions
US5871665A (en) * 1992-04-27 1999-02-16 Merck Patent Gesellschaft Mit Beschrankter Haftung Electrooptical liquid crystal system
US5886064A (en) * 1994-12-08 1999-03-23 Ivoclar Ag Fine-grained polymerizable compositions flowable under pressure or shear stress
US5897885A (en) * 1994-05-31 1999-04-27 Tec Ventures, Inc. Apparatus for molding dental restorations
US5910273A (en) * 1992-11-25 1999-06-08 Vita Zahnfabrik H. Rauter Gmbh & Co. Kg Process for manufacturing dental prosthetics based on ceramics
US5911911A (en) * 1996-04-03 1999-06-15 Basf Aktiengesellschaft Polymerized liquid-crystalline compositions
US5955514A (en) * 1993-04-19 1999-09-21 Dentsply Research & Development Corp. Dental composition and method
US5989461A (en) * 1996-07-04 1999-11-23 Merck Patent Gesellschaft Mit Beschrankter Haftung Circular UV polarizer
US5998499A (en) * 1994-03-25 1999-12-07 Dentsply G.M.B.H. Liquid crystalline (meth)acrylate compounds, composition and method
US6022404A (en) * 1995-01-12 2000-02-08 Degussa Aktiengesellschaft Surface-modified, pyrogenically produced mixed oxides, method of their production and use
US6027816A (en) * 1993-03-11 2000-02-22 Nikon Corporation Colored plastic lens and method of manufacture therefor
US6031015A (en) * 1995-07-18 2000-02-29 Ivoclar Ag Dental materials based on liquid crystalline monomers
US6060042A (en) * 1998-06-04 2000-05-09 Basf Aktiengesellschaft Use of cholesteric, liquid-crystalline compositions as UV filters in cosmetic and pharmaceutical preparations
US6087816A (en) * 1999-06-29 2000-07-11 Maxim Integrated Products, Inc. Step-up/step-down switching regulators and pulse width modulation control therefor
US6090308A (en) * 1995-02-06 2000-07-18 Merck Patent Gesellschaft Direactive mesogenic compounds and intermediates
US6117920A (en) * 1996-07-25 2000-09-12 Merck Patent Gesellschaft Mit Beschrankter Haftung Thermochromic polymerizable mesogenic composition
US6136225A (en) * 1995-09-01 2000-10-24 Basf Aktiengesellschaft Polymerizable liquid-crystalline compounds
US6144428A (en) * 1994-06-24 2000-11-07 Rolic Ag Optical component
US6194481B1 (en) * 1999-05-19 2001-02-27 Board Of Regents Of The University Of Texas System Mechanically strong and transparent or translucent composites made using zirconium oxide nanoparticles
US6204302B1 (en) * 1998-11-20 2001-03-20 Bisco, Inc. Photosensitizers for free radical polymerization initiation resins and method of making the same
US6217955B1 (en) * 1996-03-19 2001-04-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Liquid crystal display device
US6217792B1 (en) * 1996-07-01 2001-04-17 Merck Patent Gmbh Chiral dopants
US6258974B1 (en) * 1993-04-13 2001-07-10 Southwest Research Institute Metal oxide compositions composites thereof and method
US6291035B1 (en) * 1996-09-17 2001-09-18 Merck Patent Gesellschaft Mit Optical retardation film
US6303050B1 (en) * 1997-04-05 2001-10-16 Daimlerchrysler Ag Compounds, process for their manufacture, as well as a process for manufacturing liquid-crystalline polymers using these compounds
US6335462B1 (en) * 1996-11-27 2002-01-01 Basf Aktiengesellschaft Polymerizable oligomesogenes
US20020036285A1 (en) * 2000-04-03 2002-03-28 Basf Aktiengesellschaft Polymerizable liquid crystals
US6414092B1 (en) * 1996-02-15 2002-07-02 Merck Patent Gesellschaft Mit Beschraenkter Haftung Cholesteric flakes
US6417244B1 (en) * 1993-04-13 2002-07-09 Southwest Research Institute Metal oxide compositions and methods
US20030036609A1 (en) * 2001-01-23 2003-02-20 Wellinghoff Stephen T. Novel methods and blends for controlling rheology and transition temperature of liquid crystals
US20030125435A1 (en) * 2001-03-07 2003-07-03 Norling Barry K. Ultra-low shrinkage composite resins based on blended nematic liquid crystal monomers
US20030168633A1 (en) * 2001-07-09 2003-09-11 Wellinghoff Stephen T. Novel, mesogens and methods for their synthesis and use
US6649230B1 (en) * 1999-04-06 2003-11-18 Rolic Ag Photoactive polymers
US6696585B1 (en) * 1993-04-13 2004-02-24 Southwest Research Institute Functionalized nanoparticles
US20040144954A1 (en) * 2001-01-23 2004-07-29 Southwest Research Institute Selective ether cleavage synthesis of liquid crystals

Patent Citations (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201856A (en) * 1978-05-08 1980-05-06 Eastman Kodak Company Liquid crystal copolyesters containing terephthalic acid, 2,6-naphthalenedicarboxylic acid, hydroquinone and resorcinol
US4215033A (en) * 1978-09-08 1980-07-29 American Dental Association Health Foundation Composite dental material
USRE32073E (en) * 1980-09-08 1986-01-28 Minnesota Mining And Manufacturing Company Dental filling composition utilizing zinc-containing inorganic filler
US4588756A (en) * 1983-01-10 1986-05-13 American Dental Association Health Foundation Multi-step method for obtaining strong adhesive bonding of composites to dentin, enamel and other substrates
US4659751A (en) * 1983-01-10 1987-04-21 American Dental Association Health Foundation Simplified method for obtained strong adhesive bonding of composites to dentin, enamel and other substrates
US4539048A (en) * 1983-02-09 1985-09-03 Jos. Cavedon Company Inc. Aluminum zirconium metallo-organic complexes useful as coupling agents
US4753652A (en) * 1984-05-04 1988-06-28 Children's Medical Center Corporation Biomaterial implants which resist calcification
US5276068A (en) * 1985-03-29 1994-01-04 Jeneric/Pentron, Inc. Dental resin materials
US4623738A (en) * 1985-04-22 1986-11-18 Kenrich Petrochemicals, Inc. Neoalkoxy organo-titanates and organo-zirconates useful as coupling and polymer processing agents
US4663147A (en) * 1985-09-03 1987-05-05 International Minerals & Chemical Corp. Disc-like sustained release formulation
US5057018A (en) * 1986-05-13 1991-10-15 American Dental Association - Health Foundation Microcrystalline inserts for megafilled composite dental restorations
US4914221A (en) * 1987-08-13 1990-04-03 Consortium Fur Elektrochemische Industrie Gmbh Dimethylsilyl-substituted benzoyl chlorides and a process for preparing the same
US4964911A (en) * 1987-10-13 1990-10-23 Den-Mat Corporation Adhesive bonding of acrylic resins, especially in dentistry
US4978640A (en) * 1988-02-24 1990-12-18 Massachusetts Institute Of Technology Dispersion strengthened composite
US5064877A (en) * 1988-07-18 1991-11-12 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Process for fixing inorganic species in an organic matrix
US5334625A (en) * 1989-04-06 1994-08-02 Den-Mat Corporation Restorative dental adhesive composition
US5024850A (en) * 1989-05-10 1991-06-18 U.S. Philips Corporation Method of manufacturing a polarization filter and a polarization filter so obtained
US5030608A (en) * 1989-08-23 1991-07-09 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Process for the preparation of composite materials which contain small particles of metal or metal oxide in an oxide matrix and the composite materials prepared by the process
US5073294A (en) * 1990-03-07 1991-12-17 Hercules Incorporated Process of preparing compositions having multiple oriented mesogens
US5308886A (en) * 1990-04-20 1994-05-03 Japan Institute Of Advanced Dentistry Photosetting resin for making strong, tough resin articles
US5202053A (en) * 1991-02-22 1993-04-13 Hercules Incorporated Polymerizable nematic monomer compositions
US5401528A (en) * 1991-03-19 1995-03-28 Thera Patent GmbH & Co. KG Geselleschaft fur industrielle Schutzrechte Use of compositions based on organically modified silicic acid polycondensates for coating teeth and dental prostheses
US5328947A (en) * 1991-12-27 1994-07-12 Denki Kagaku Kogyo Kabushiki Kaisha Two-part adhesive
US5871665A (en) * 1992-04-27 1999-02-16 Merck Patent Gesellschaft Mit Beschrankter Haftung Electrooptical liquid crystal system
US5472797A (en) * 1992-07-07 1995-12-05 Hoya Corporation Optical elements having cured coating film
US5910273A (en) * 1992-11-25 1999-06-08 Vita Zahnfabrik H. Rauter Gmbh & Co. Kg Process for manufacturing dental prosthetics based on ceramics
US6027816A (en) * 1993-03-11 2000-02-22 Nikon Corporation Colored plastic lens and method of manufacture therefor
US5670583A (en) * 1993-04-13 1997-09-23 Southwest Research Institute Metal oxide-polymer composites
US6743936B1 (en) * 1993-04-13 2004-06-01 Southwest Research Insittute Composites made using functionalized nanoparticles
US6696585B1 (en) * 1993-04-13 2004-02-24 Southwest Research Institute Functionalized nanoparticles
US6410765B1 (en) * 1993-04-13 2002-06-25 Southwest Research Institute Methods of making functionalized nanoparticles
US6417244B1 (en) * 1993-04-13 2002-07-09 Southwest Research Institute Metal oxide compositions and methods
US5372796A (en) * 1993-04-13 1994-12-13 Southwest Research Institute Metal oxide-polymer composites
US6258974B1 (en) * 1993-04-13 2001-07-10 Southwest Research Institute Metal oxide compositions composites thereof and method
US5720805A (en) * 1993-04-13 1998-02-24 Southwest Research Institute Titanium-tin-oxide nanoparticles, compositions utilizing the same, and the method of forming the same
US6695617B1 (en) * 1993-04-13 2004-02-24 Southwest Research Institute Methods of dental repair using functionalized nanoparticles
US5955514A (en) * 1993-04-19 1999-09-21 Dentsply Research & Development Corp. Dental composition and method
US5502087A (en) * 1993-06-23 1996-03-26 Dentsply Research & Development Corp. Dental composition, prosthesis, and method for making dental prosthesis
US5486548A (en) * 1993-07-21 1996-01-23 Bayer Aktiengesellschaft Acrylates and methacrylates based on cyclohexyldiphenols
US5834532A (en) * 1993-08-02 1998-11-10 Sun Medical Co., Ltd. Primer composition and curable composition
US5804097A (en) * 1993-09-25 1998-09-08 Basf Aktiengsellschaft Liquid-crystalline compounds
US5622648A (en) * 1993-10-15 1997-04-22 Merck Patent Gesellschaft Mit Beschrankter Haftung Reactive liquid crystal compounds
US5833880A (en) * 1994-03-11 1998-11-10 Basf Aktiengesellschaft Polymerizable liquid-crystalline compounds
US5624976A (en) * 1994-03-25 1997-04-29 Dentsply Gmbh Dental filling composition and method
US5998499A (en) * 1994-03-25 1999-12-07 Dentsply G.M.B.H. Liquid crystalline (meth)acrylate compounds, composition and method
US5897885A (en) * 1994-05-31 1999-04-27 Tec Ventures, Inc. Apparatus for molding dental restorations
US6144428A (en) * 1994-06-24 2000-11-07 Rolic Ag Optical component
US5556931A (en) * 1994-07-08 1996-09-17 Tokuyama Corporation Polymerizable composition and organic glass
US5563230A (en) * 1994-09-09 1996-10-08 National Science Council Chiral smectic liquid crystalline polymers
US5654471A (en) * 1994-12-01 1997-08-05 Consortium Fur Elektrochemische Industrie Gmbh Process for the preparation of 4-hydroxyphenyl benzoate derivatives
US5886064A (en) * 1994-12-08 1999-03-23 Ivoclar Ag Fine-grained polymerizable compositions flowable under pressure or shear stress
US6022404A (en) * 1995-01-12 2000-02-08 Degussa Aktiengesellschaft Surface-modified, pyrogenically produced mixed oxides, method of their production and use
US6090308A (en) * 1995-02-06 2000-07-18 Merck Patent Gesellschaft Direactive mesogenic compounds and intermediates
US5695681A (en) * 1995-03-30 1997-12-09 Basf Aktiengesellschaft Liquid-crystalline allenes
US5663214A (en) * 1995-04-17 1997-09-02 Gc Corporation Photocuring denture base lining material
US6031015A (en) * 1995-07-18 2000-02-29 Ivoclar Ag Dental materials based on liquid crystalline monomers
US6136225A (en) * 1995-09-01 2000-10-24 Basf Aktiengesellschaft Polymerizable liquid-crystalline compounds
US6414092B1 (en) * 1996-02-15 2002-07-02 Merck Patent Gesellschaft Mit Beschraenkter Haftung Cholesteric flakes
US5730601A (en) * 1996-03-11 1998-03-24 The Regents Of The University Of Colorado Method and material for use with dental composites for improving conversion of monomers to polymers and reducing volume shrinkage
US6217955B1 (en) * 1996-03-19 2001-04-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Liquid crystal display device
US5911911A (en) * 1996-04-03 1999-06-15 Basf Aktiengesellschaft Polymerized liquid-crystalline compositions
US6217792B1 (en) * 1996-07-01 2001-04-17 Merck Patent Gmbh Chiral dopants
US5989461A (en) * 1996-07-04 1999-11-23 Merck Patent Gesellschaft Mit Beschrankter Haftung Circular UV polarizer
US6117920A (en) * 1996-07-25 2000-09-12 Merck Patent Gesellschaft Mit Beschrankter Haftung Thermochromic polymerizable mesogenic composition
US6291035B1 (en) * 1996-09-17 2001-09-18 Merck Patent Gesellschaft Mit Optical retardation film
US6335462B1 (en) * 1996-11-27 2002-01-01 Basf Aktiengesellschaft Polymerizable oligomesogenes
US5808108A (en) * 1997-01-15 1998-09-15 Chappelow; Cecil C. Polymeric compositions and composites prepared from spiroorthocarbonates and epoxy monomers
US5865623A (en) * 1997-03-12 1999-02-02 Bisco, Inc. Flexible dental composite compositions and restorative methods using flexible dental compositions
US6303050B1 (en) * 1997-04-05 2001-10-16 Daimlerchrysler Ag Compounds, process for their manufacture, as well as a process for manufacturing liquid-crystalline polymers using these compounds
US5859089A (en) * 1997-07-01 1999-01-12 The Kerr Corporation Dental restorative compositions
US5852248A (en) * 1998-05-21 1998-12-22 Den-Mat Corporation Method for accurate replication of shaped articles using sinterable powders
US6060042A (en) * 1998-06-04 2000-05-09 Basf Aktiengesellschaft Use of cholesteric, liquid-crystalline compositions as UV filters in cosmetic and pharmaceutical preparations
US6204302B1 (en) * 1998-11-20 2001-03-20 Bisco, Inc. Photosensitizers for free radical polymerization initiation resins and method of making the same
US6649230B1 (en) * 1999-04-06 2003-11-18 Rolic Ag Photoactive polymers
US20020013382A1 (en) * 1999-05-19 2002-01-31 Furman Benjamin L. Methods of functionalizing and functionalized metal oxide particles and mechanically strong and transparent or translucent composites made using such particles
US6194481B1 (en) * 1999-05-19 2001-02-27 Board Of Regents Of The University Of Texas System Mechanically strong and transparent or translucent composites made using zirconium oxide nanoparticles
US6087816A (en) * 1999-06-29 2000-07-11 Maxim Integrated Products, Inc. Step-up/step-down switching regulators and pulse width modulation control therefor
US20020036285A1 (en) * 2000-04-03 2002-03-28 Basf Aktiengesellschaft Polymerizable liquid crystals
US6699405B2 (en) * 2000-04-03 2004-03-02 Basf Aktiengesellschaft Polymerizable liquid crystals
US20030036609A1 (en) * 2001-01-23 2003-02-20 Wellinghoff Stephen T. Novel methods and blends for controlling rheology and transition temperature of liquid crystals
US20030055280A1 (en) * 2001-01-23 2003-03-20 Wellinghoff Stephen T. Methods for synthesis of liquid crystals
US20040144954A1 (en) * 2001-01-23 2004-07-29 Southwest Research Institute Selective ether cleavage synthesis of liquid crystals
US20030125435A1 (en) * 2001-03-07 2003-07-03 Norling Barry K. Ultra-low shrinkage composite resins based on blended nematic liquid crystal monomers
US20030168633A1 (en) * 2001-07-09 2003-09-11 Wellinghoff Stephen T. Novel, mesogens and methods for their synthesis and use

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037583B2 (en) 1999-05-19 2006-05-02 Southwest Research Institute Functionalized zirconium oxide particles
US20020013382A1 (en) * 1999-05-19 2002-01-31 Furman Benjamin L. Methods of functionalizing and functionalized metal oxide particles and mechanically strong and transparent or translucent composites made using such particles
US7108801B2 (en) 2001-01-23 2006-09-19 Southwest Reasearch Institute Methods and blends for controlling rheology and transition temperature of liquid crystals
US7041234B2 (en) 2001-01-23 2006-05-09 Southwest Research Institute Methods for synthesis of liquid crystals
US7238831B2 (en) 2001-01-23 2007-07-03 Southwest Research Institute Mesogens
US7147800B2 (en) 2001-01-23 2006-12-12 Southwest Research Institute Selective ether cleavage synthesis of liquid crystals
US20040144954A1 (en) * 2001-01-23 2004-07-29 Southwest Research Institute Selective ether cleavage synthesis of liquid crystals
US20020177727A1 (en) * 2001-01-23 2002-11-28 Wellinghoff Stephen T. Novel mesogens
US20030036609A1 (en) * 2001-01-23 2003-02-20 Wellinghoff Stephen T. Novel methods and blends for controlling rheology and transition temperature of liquid crystals
US20030055280A1 (en) * 2001-01-23 2003-03-20 Wellinghoff Stephen T. Methods for synthesis of liquid crystals
US7094358B2 (en) 2001-03-07 2006-08-22 The University Of Texas System Ultra-low shrinkage composite resins based on blended nematic liquid crystal monomers
US20040206934A1 (en) * 2001-03-07 2004-10-21 Board Of Regents, The University Of Texas System Ultra-low shrinkage composite resins based on blended nematic liquid crystal secondary monomers
US7135589B2 (en) 2001-03-07 2006-11-14 Board Of Regents, The University Of Texas System Bridged monomers
US20030125435A1 (en) * 2001-03-07 2003-07-03 Norling Barry K. Ultra-low shrinkage composite resins based on blended nematic liquid crystal monomers
US7098359B2 (en) 2001-07-09 2006-08-29 Southwest Research Institute Mesogens and methods for their synthesis and use
US20030168633A1 (en) * 2001-07-09 2003-09-11 Wellinghoff Stephen T. Novel, mesogens and methods for their synthesis and use

Similar Documents

Publication Publication Date Title
EP1366133B1 (en) Novel methods and blends for controlling rehology and transition temperature of liquid crystals
EP2130843B1 (en) Polymerizable compounds and polymerizable compositions
EP2110390B1 (en) Polymerizable composition
US20050189516A1 (en) Resin blends and methods for making same
US20020060310A1 (en) Polymerizable compound, polymerizable liquid crystal composition containing the same, and optically anisotropic medium made from the composition
JP4207233B2 (en) Liquid crystal composition and optical anisotropic body using the same
US20050040364A1 (en) Liquid crystalline laterally polymerizable compounds
US20040199004A1 (en) Novel mesogens
US7147800B2 (en) Selective ether cleavage synthesis of liquid crystals
JP5337064B2 (en) Liquid crystal synthesis method
JP3900987B2 (en) Optically active fumaric acid diester derivative and liquid crystal polymer thereof
JP4363832B2 (en) Polymerizable liquid crystal composition and polymer dispersed liquid crystal obtained by polymerizing the polymerizable liquid crystal composition
JP4088863B2 (en) Fumaric acid diester and its liquid crystalline polymer
JP3972430B2 (en) Liquid crystalline (meth) acrylate compound, composition containing the compound, and optical anisotropic body using the same
JP3832301B2 (en) Liquid crystalline fumaric acid diester and its polymer

Legal Events

Date Code Title Description
AS Assignment

Owner name: SOUTHWEST RESEARCH INSTITUTE, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WELLINGHOFF, STEPHEN T.;HANSON, DOUGLAS P.;REEL/FRAME:014732/0488

Effective date: 20040525

STCB Information on status: application discontinuation

Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION

AS Assignment

Owner name: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF

Free format text: CONFIRMATORY LICENSE;ASSIGNOR:SOUTHWEST RESEARCH INSTITUTE;REEL/FRAME:021977/0587

Effective date: 20040616